A discussion of how the changing narrative of ageing is impacting men’s experience with prostate cancer with TFTC consultant Urologist Raj Nigam.

Journalist and publisher Graham Ogilvy joins On Focus to discuss his recent experience with a prostate cancer diagnosis in Scotland that ultimately led him to seek treatment in England, and offers strong advice for men in Scotland to question the “blunt instruments” that are the default diagnostic and treatment offer there.

Tony Collier, ambassador, awareness speaker and fundraiser for Prostate Cancer UK joins Clare to discuss his campaigns and the messages he wants every man and his loved ones to hear regarding prostate cancer.

In May 2017, while training for an ultra marathon, Tony was told that a groin strain was in fact prostate cancer that had spread to the pelvic bone and was working its way throughout his skeletal system. In his words, “a worst case prognosis of two years was a real shock but I was even more shocked when I discovered that if I’d requested a PSA blood test every year from age 50 I could have had curative treatment. If only I’d known! Now it’s my mission to make sure other men know”.

In recognition of Black History Month, this episode of On Focus builds on the stark fact that black men are diagnosed with prostate cancer at twice the rate of white men, and invites a leader in London’s black community to explore the reasons why.

Jonathan Oloyede is a British Nigerian who trained as a medical doctor and now serves as a full-time missionary and minister in England and Europe. He is founder and leader at City Chapel in East London, which among its many community outreach programmes supports local health initiatives including a man-to-man mentoring project. In this episode, he discusses the challenges that men in his community face regarding their health, and how he is playing a key role in supporting  them.

Alan Doherty, Clinical director of the Birmingham Prostate Clinic, discusses how variation in MRI reporting methods affects diagnostic and treatment decisions, and offers advice to patients on ensuring that they are getting best practice from their MRI scan.

Alex González from Sonacare Medical, leading developers of HIFU systems for prostate cancer, explains the origins of HIFU technology and how it has developed to become a powerful non-invasive treatment for prostate cancer.

Chris Lewis, founder of one of the UK’s largest and most influential online cancer communities, joins Clare to discuss how cancer communities are evolving to support many cancer patients, not just as a source of communal solace but as a powerful political and media advocate for patient rights and improved services.

Consultant Urologist Raj Nigam discusses how age discrimination occurs in prostate cancer treatment, and shares his thoughts on how older men can address this.

TFTC patient Mark Stubbs discusses how seeking a second opinion for his prostate cancer diagnosis and treatment led to an unforeseen approach and better outcome.

Consultant Urologist Tim Dudderidge discusses the stages in the imaging-led prostate cancer diagnostic pathway, and outlines what patients need to know.